HeartFusion 2025 welcomes submissions from researchers, clinicians, and innovators dedicated to advancing cardiovascular care through biotechnology, bioengineering, and translational research. This is an excellent opportunity to present your work to a distinguished international audience, engage in scholarly discourse, and contribute to shaping the future of cardiovascular health.
Key Topics
We encourage abstracts addressing cutting-edge research and practical applications in cardiovascular science, with a particular focus on:
- Preventive Cardiology
- Cardiovascular Disease in Special Populations
- Advanced Heart Failure and Cardiogenic Shock
- Cardiac Arrhythmia and Device Therapy
- Digital and AI Applications in Cardiac Care
- Coronary Artery Disease
- Vascular Medicine
- Biotechnology Applications in Cardiac Care
We also welcome submissions in related areas including clinical case studies, translational research, innovative technologies, and systematic reviews that align with these themes.
Submission Guidelines
- Abstract Length: Maximum 300 words
- Structure: Title, Authors, Unit/Department, Background, Aim, Method and Design, Results and Conclusion
- Formatting: Times New Roman, 12 pt, single-spaced
- Authors: Include title, full names, institutional affiliations, and corresponding email
- Language: English
- Submission: Online only via https://heartfusion.com
Eligibility & Conditions
- Abstracts must be original and not previously published.
- Only one primary abstract per presenting author will be considered.
- All presenting authors are required to register for the conference.
- The Scientific Committee reserves the right to accept, reject, or reassign abstracts to the most suitable session.
- Accepted abstracts will be published and displayed during the conference poster sessions.
Key Dates
- Submission Deadline: October 10, 2025
- Notification of Acceptance: October 20, 2025
- Final poster submission for selected abstracts: October 26, 2025
Benefits of Participation
- Present your work to an international, multidisciplinary audience of cardiovascular and bioengineering experts.
- Receive peer feedback and recognition from a distinguished Scientific Committee.
- Contribute to advancing cardiovascular care and technology adoption globally.
- Participate in networking, collaboration, and mentorship opportunities with leaders in cardiology and biotechnology.
Submit today and be part of HeartFusion 2025!
